Epidemiology, control and treatment of multidrug-resistant tuberculosis.
Chaulet
P
P
WHO, Global Tuberculosis Programme, Geneva, Switzerland.
Raviglione
M
M
Bustreo
F
F
D000995:Antitubercular Agents / Q000627:therapeutic use*; D003906:Developing Countries; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use*; D012293:Rifampin / Q000627:therapeutic use*; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control
D000995:Antitubercular Agents; D007538:Isoniazid; D012293:Rifampin